Starting from October, there will be no restrictions on prescribing the hyperlipidemia medication Rosuvastatin.

Category

Health

Listed

28 September 2026

Starting October 1st, the conditions for receiving subsidized **Rosuvastatin**, used to treat hyperlipidemia in New Zealand, will be significantly relaxed. Until now, to prescribe Rosuvastatin with government support, patients had to meet certain criteria, and medical professionals had to **apply for a separate approval called Special Authority**. However, from October 1st, this restriction will be removed, allowing medical professionals to prescribe subsidized Rosuvastatin if they deem it nece…

View this listing on Maru Community

Maru Community — the marketplace for the Korean community abroad